Odyssey Health (ODYY) Cash & Current Investments (2014 - 2026)
Odyssey Health (ODYY) posted quarterly Cash & Current Investments of $297806.0 for Q2 2026, up 9247.33% year-over-year from $3186.0 in Q2 2025, and down 51.68% quarter-over-quarter from $616327.0 in Q1 2026.
Odyssey Health (ODYY) Cash & Current Investments (2014 - 2026) Analysis & Trends
Odyssey Health's Cash & Current Investments history runs 13 years deep, the most recent figure standing at $297806.0 for Q2 2026.
- In Q2 2026, Cash & Current Investments rose 9247.33% year-over-year to $297806.0; the TTM figure through Apr 2026 stood at $297806.0 (up 9247.33% YoY), while the FY2025 annual figure was $19084.0, up 702.19% from the prior year.
- Cash & Current Investments for Q2 2026 stood at $297806.0, down from $616327.0 in the prior quarter.
- The five-year high for Cash & Current Investments was $616327.0 in Q1 2026, with the low at $1234.0 in Q2 2023.
- The 5-year median for Cash & Current Investments is $52182.0 (2022), against an average of $113889.8.
- The sharpest annual moves came in 2023 and 2026: Cash & Current Investments slumped 99.54% in 2023, then surged 9247.33% in 2026.
- Odyssey Health's Cash & Current Investments stood at $50499.0 in 2022, then jumped by 291.85% to $197882.0 in 2023, then plunged by 72.78% to $53865.0 in 2024, then plunged by 52.5% to $25586.0 in 2025, then soared by 1063.94% to $297806.0 in 2026.
- Business Quant data shows ODYY's Cash & Current Investments at $297806.0 in Q2 2026, $616327.0 in Q1 2026, and $25586.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 3.48 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 4.25 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 1.95 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 3.32 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Odyssey Health | 1.07 Mn | 771,705.04 | - | 297,806.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 297,806.00 |
| Jan 31, 2026 | 616,327.00 |
| Oct 31, 2025 | 25,586.00 |
| Jul 31, 2025 | 19,084.00 |
| Apr 30, 2025 | 3,186.00 |
| Jan 31, 2025 | 7,187.00 |
| Oct 31, 2024 | 53,865.00 |
| Jul 31, 2024 | 2,379.00 |
| Apr 30, 2024 | 66,014.00 |
| Jan 31, 2024 | 166,140.00 |
| Oct 31, 2023 | 197,882.00 |
| Jul 31, 2023 | 36,865.00 |
| Apr 30, 2023 | 1,234.00 |
| Jan 31, 2023 | 35,792.00 |
| Oct 31, 2022 | 50,499.00 |
| Jul 31, 2022 | 72,534.00 |
| Apr 30, 2022 | 266,300.00 |
| Jan 31, 2022 | 131,337.00 |
| Oct 31, 2021 | 471,140.00 |
| Jul 31, 2021 | 72,534.00 |